Raphael Pharmaceutical (RAPH) Assets Growth (1y) (2021 - 2025)
Raphael Pharmaceutical (RAPH) Assets Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 96.30% |
| Sep 30, 2025 | -86.27% |
| Jun 30, 2025 | -76.56% |
| Mar 31, 2025 | -73.65% |
| Dec 31, 2024 | -88.70% |
| Sep 30, 2024 | -87.34% |
| Jun 30, 2024 | 7.56% |
| Mar 31, 2024 | 135.33% |
| Dec 31, 2023 | -28.23% |
| Sep 30, 2023 | 233.06% |
| Jun 30, 2023 | -39.29% |
| Mar 31, 2023 | -16.67% |
| Dec 31, 2022 | -21.09% |
| Sep 30, 2022 | 95.16% |
| Dec 31, 2021 | 30.65% |